RBC Capital lowered the firm’s price target on Bausch Health (BHC) to $8.50 from $9 and keeps a Sector Perform rating on the shares. The firm ...

Trump's tariff move spurs RBC's second S&P 500 downgrade this year as macro stress builds across equity markets ...

RBC cuts its 2025 S&P target by 11% to 5,550, seeing a growth scare rising amid Trump tariffs. Read more here.

RBC Capital analyst Michael Siperco maintained a Buy rating on Centerra Gold (CGAU – Research Report) yesterday and set a price target of ...

Fintel reports that on April 2, 2025, RBC Capital downgraded their outlook for Beacon Roofing Supply (NasdaqGS:BECN) from ...

RBC Capital initiated coverage of BeiGene (ONC) with an Outperform rating and $312 price target RBC sees a path to robust revenue growth driven by ...

The firm's latest additions, including two brothers, bolster its employee advisor business in Scottsdale, Arizona.

), which finalizes its aircraft in Canada and reported that 63% of its 2023 revenues came from the U.S., as being ...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief ...

Barclays on Wednesday became the latest brokerage after Goldman Sachs and RBC Capital Markets to slash its year-end target ...

Head of equities Karen Jorritsma told staff in an internal memo on Thursday the investment bank had lured across Sutton from ...

Investing.com -- Analysts at RBC Capital Markets have upgraded ABN AMRO (AS: ABNd) Bank N.V. to an "outperform" rating from a previous "Sector Perform," with a price target of €23, in a note dated ...